Evaluating pulmonary complications in childhood acute leukemias

Barş Erdur1, Sebnem Yilmaz, Hale Oren

  • 1Department of Pediatric Hematology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey.

Abstract

Insights

Pulmonary complications are common in children with acute leukemia, with infections being the primary cause. Early diagnosis and management are crucial, especially during intensive chemotherapy phases, to reduce mortality risks.

Area of Science:

  • Pediatric Oncology
  • Pulmonology
  • Infectious Diseases

Background:

  • Pulmonary complications are a significant concern in pediatric acute leukemia patients.
  • These complications contribute to morbidity and mortality, necessitating a thorough understanding of their causes and outcomes.

Purpose of the Study:

  • To investigate the frequency, causes, outcomes, and associated factors of pulmonary complications in children with acute leukemia.
  • To identify risk factors for mortality related to these complications.

Main Methods:

  • Retrospective evaluation of 163 pediatric acute leukemia patients.
  • Analysis of pulmonary complication incidence, etiology (infectious and non-infectious), and patient outcomes.
  • Identification of factors associated with increased mortality risk.

Main Results:

  • Pulmonary complications occurred in 40.4% of patients (79 events in 66 patients).
  • Infectious causes predominated (92.4%), with Gram-negative bacteria and fungi being most common.
  • Non-infectious causes included acute respiratory distress syndrome and leukostasis.
  • Complications during induction/consolidation phases were more severe with higher mortality (8.9%).
  • Tachypnea, shock, mechanical ventilation, DIC, multi-organ involvement, cytopenias, and altered antimicrobial therapy predicted higher mortality.

Conclusions:

  • Pulmonary complications are frequent and potentially fatal in pediatric acute leukemia.
  • Prompt diagnosis and management are vital, particularly for neutropenic patients undergoing induction or consolidation chemotherapy.
  • Understanding risk factors aids in optimizing patient care and reducing mortality.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...